Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05361304 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.
A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 6
- Study locations
NCT05361304: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.
NCT05361304 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 123 participants, roughly in line with the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target. The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05361304, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is a feasibility, multi-site, randomized, double-masked, 2-arm parallel group design, 2-week dispensing study with weekly visits to evaluate visual acuity.
Primary Outcome
Monocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance low contrast (HLLC), and low luminance high contrast (LLHC) at distance (4 meters) using an ETDRS (Early Treatment Diabetic Retinopathy Study) charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better visual acuity. A logMAR visual performance score of 0.0 is equivalent to Snellen
Conditions Studied
Interventions
- DEVICE senofilcon A contact lenses made with a novel manufacturing technology
- DEVICE senofilcon A contact lenses made with the current manufacturing technology
Study Locations (6)
Florida
- VRC - Jacksonville
- Flora Chen Poveda OD, PA - Orange Park - Orange Park
- Tallahassee Eye Center - Tallahassee
New York
- Sacco Eye Group - Vestal
Utah
- William J. Bogus, O.D. - Salt Lake City
Virginia
- Botetourt Eyecare, LLC - Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2022-07-05 |
| Phase | NA |
What the finished NCT05361304 record still lists
NCT05361304 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 134-participant average among 20 other Visual Acuity trials with a reported enrollment target.
The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A contact lenses made with a novel manufacturing technology is the first listed.
NCT05361304 lists 6 locations in 4 states (Florida, New York, Utah).
Frequently Asked Questions
What is clinical trial NCT05361304 about?
NCT05361304 is a clinical study titled "Clinical Evaluation of Senofilcon A Contact Lenses Using a Novel Manufacturing Technology to Evaluate Overall Visual Acuity.". This study is a feasibility, multi-site, randomized, double-masked, 2-arm parallel group design, 2-week dispensing study with weekly visits to evaluate visual acuity.
What is the current status of trial NCT05361304?
This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2022-05-16. Estimated completion is 2022-07-05.
What conditions does trial NCT05361304 study?
This clinical trial studies the following conditions: Visual Acuity.
What interventions are being tested in trial NCT05361304?
The interventions under investigation include: senofilcon A contact lenses made with a novel manufacturing technology (DEVICE), senofilcon A contact lenses made with the current manufacturing technology (DEVICE).
Who is sponsoring clinical trial NCT05361304?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05361304 being conducted?
This trial has 6 study locations across Florida, New York, Utah, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Acuity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05361304's enrollment target sits among peer trials
123 7th of 20 higher than 14 of 20 other Visual Acuity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Effect of Scatter on Visual Performance
RECRUITING · NA
-
Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population Phase 2
COMPLETED · NA
-
Evaluation of Daily Disposable Silicone Hydrogel Multifocal Toric Contact Lenses
COMPLETED · NA
-
Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
COMPLETED · NA
-
Clinical Evaluation of Approved Contact Lenses
COMPLETED · NA
-
Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI